For Elizabeth Adams, a first-year medical student, donning her white coat felt like the culmination of one journey and the beginning of another.
Monthly Archives: September, 2020
A snowflake-shaped nanoparticle greatly enhanced the combination of radiotherapy and immunotherapy in mouse models of prostate cancer.
Feinberg educators celebrated teaching and learning virtually at the tenth annual Medical Education Day.
The drug rucaparib significantly delayed cancer progression for women with ovarian cancer and may be an effective option for maintenance therapy, according to findings from a recent clinical trial.
A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.
A recent Northwestern Medicine study has revealed previously unknown details about calcium signaling that can contribute to inflammation.
Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.
Feinberg principal investigators secured a record-breaking $643 million in research funding and awards during the 2019-2020 fiscal year.
Men with advanced prostate cancer who were treated based on the genetic makeup of their cancer survived significantly longer than those treated with standard treatments, according to a new study.